Comparative evaluation of the activity and clinical effectiveness of terbinafine and bifonazole preparations in the treatment of pedal mycosis;Vergleichende bewertung der wirkung und klinischen wirksamkeit von terbinafinhaltigen und bifonazolhaltigen topika bei der behandlung der fußmykose

Aktuelle Dermatologie

Volumn 30, Issue 6, 2004, Pages 210-217

  Korting, Hans C ^a,c   Kresimon, Jutta ^b   Rychlik, R ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Inst Empirische Gesundheitsokonom   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIFONAZOLE; PLACEBO; TERBINAFINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; FUNGICIDAL ACTIVITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REVIEW; SIDE EFFECT; STRATUM CORNEUM; TINEA PEDIS; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 3042783564     PISSN: 03402541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814541     Document Type: Review

References (41)

1. Arbeitsgemeinschaft der wissenschaftlichen medizinischen Fachgesellschaft (AWMF). Das Leitlinien-Manual von AWMF und ÄZQ. Z Ärztl Fortbild Qualitätssich 2001; 95: 1-84
2. AWMF Deutsche Dermatologische Gesellschaft und Deutschsprachigen Mykologische Gesellschaft. Leitlinien Tinea der freien Haut, Nov. 2002, http://www.uni-duesseldorf.de/AWMF/11/derm-m01.html
3. Braun-Falco O, Plewig G, Wolff HH. Dermatologie und Venerologie. Berlin: Springer Verlag, 1984: 211-212
4. Aste N, Pau M, Aste N, Biggio P. Tinea pedis observed in Cagliari, Italy, between 1996 and 2000. Mycoses 2003; 46: 38-41
5. Kemna ME, Elewski BE. A U.S. epidemiologic survey of superficial fungal diseases. J Am Acad Dermatol 1996; 35: 539-542
6. Maruyama R, Hiruma M, Yamauchi K, Teraguchi S, Yamaguchi H. An epidemiological and clinical study of untreated patients with tinea pedis within a company in Japan. Mycoses 2003; 46: 208-212
7. Summerbell RC, Kane J, Krajden S. Onychomycosis, tinea pedis and tinea manuum caused by non-dermatophytic filamentos fungi. Mycoses 1989; 32: 609-619
8. Stenderup A. Ecology of yeast and epidemiology of yeast infections. Acta Derm venereol (Stockh) 1986; Suppl 121: 27-37
9. Berg D, Plempel M. Bifonazole, a biochemist's view. Dermatologica 1984; 169: 3-10
10. Plempel M, Regel E, Büchel KH. Antimycotic efficacy of bifonazole in vitro and in vivo. Arzneimittelforschung 1983; 33: 517-524
11. Yamaguchi H, Hiratani T, Plempel M. In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole. Arzneim-Forsch Drug Res 1983; 33: 546-555
12. Seebacher C. Dermatomykosen - Grundlagen und Therapie. Heidelberg: Springer Verlag, 2001: 41
13. 14C] bifonazole. Arzneim-Forsch 1983; 33: 745-750
14. Plempel M, Berg D, Ritter W. Bifonazole, a new topical azole antimycotic with specific properties. In: Hay RJ. Advances in topical antifungal therapy. Berlin: Springer Verlag, 1986: 4-20
15. Ryder NS. The mechanism of action of terbinafine. Clin Exp Dermatol 1989; 14: 98-100
16. Ryder NS. Terbinafin: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol 1992; 126: 2-7
17. Faergemann J, Zehender H, Jones T, Maibach I. Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat. Acta Derm Venereol 1991; 71: 322-326
18. Hill S, Thomas R, Smith SG, Finlay AY. An investigation of the pharmacokinetics of topical terbinafine (Lamisil®) 1% cream. Br J Dermatol 1992; 127: 396-400
19. Tanuma H, Doi M, Ohta Y, Nishiyama S, Katsuoka K, Kaneko S, Mukai H, Abe M. Usefulness of 1% terbinafine HCl (Lamisil®) cream for hyperkeratotic-type tinea pedis and its transfer into the horny layer. Mycoses 2000; 43: 417-432
20. Dykes PJ, Thomas R, Lever I, Marks R. Pharmacokinetics of topically applied terbinafine: results from studies in healthy volunteer subjects and patients with pityriasis versicolor. J Dermatol Treat 1990; 1: 19-21
21. Clayton YM. In vitro activity of terbinafine. Clin Exp Dermatol 1989; 14: 101-103
22. Korting HC, Ollert M, Abeck D. Results of German multicentre study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. Antimicrob Agents Chemother 1995; 39: 1206-1208
23. Petranyi G, Meingassner JG, Mieth H. Antifungal activity of the allylamine derivative terbinafine in vitro. Antimicrob Agents Chemother 1987; 31: 1365-1368
24. Carrillo-Munzo AJ, Tur-Tur C. Comparative study of antifungal activity of sertaconazole, terbinafine, and bifonazole against clinical isolates of candida spp., Cryptococcus neoformans and dermatophytes. Chemotherapy 1997; 43: 387-392
25. Bagatell FK. Elimination of dermatophytes causing tinea pedis interdigitalis with once-daily application of bifonazole 1% solution. Adv Ther 1986; 3: 265-271
26. Coffey WJ. Management of tinea pedis interdigitalis with bifonazole 1% cream - double-blind study. Adv Ther 1986; 3: 301-307
27. Izuno GT. A double-blind study of bifonazole 1% cream applied once daily in the treatment of tinea (pityriasis) versicolor and tinea pedis interdigitalis. Adv Ther 1986; 3: 308-316
28. Smith EB, Tschen E. Treatment of interdigital tinea pedis and tinea (pityriasis) versicolor with bifonazole 1% solution applied once daily. Adv Ther 1986; 3: 250-256
29. Berman B, Ellis C, Leyden J, Lowe N, Savin RC, Shupack J, Stiller M, Tschen E, Zaias N, Birnbaum JE. Efficacy of a 1 week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis: results of placebo-controlled, double-blind, multicentre trials. J Am Acad Dermatol 1992; 26: 956-960
30. Hollmen KA, Kinnunen T, Kiistala U, Väänänen A, Saarelainen IO, de Cuyper C, Decroix J, Broeckx W, Karvonen J. Efficacy and tolerability of terbinafine 1% emulsion gel in patients with tinea pedis. Eur Acad Dermatol Venerol 2002; 16: 87-88
31. Korting HC, Tietz HJ, Bräutigam M, Mayser P, Rapatz G, Paul C. One week terbinafine 1% cream (Lamisil) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. Med Mycol 2001; 39: 335-340
32. Lebwohl M, Elewski B, Eisen D, Savin RC. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris. Cutis 2001; 67: 261-266
33. Savin RC. Treatment of chronic tinea pedis (athlete's foot type) with topical terbinafine. J Am Acad Dermatol 1990; 23: 786-789
34. Smith EB, Noppakun N, Newton RC. A clinical trial of topical terbinafine (a new allylamine antifungal) in the treatment of tinea pedis. J Am Acad Dermatol 1990; 23: 790-794
35. Savin RC, Atton AV, Bergstresser PR, Elewski B, Jones HE, Levine N, Leyden J, Monroe A, Pandya A, Shupack J, Stiller M, Tschen E, Weinstein G, Zaias N, Birnbaum JE. Efficacy of terbinafine 1% cream in the treatment of moccasin-type tinea pedis: Results of placebo-controlled multicentre trials. J Am Acad Dermatol 1994; 30: 663-667
36. Evans EGV, James IGV, Joshipura RC. Two-week treatment of tinea pedis with terbinafine (Lamisil) 1% cream: a placebo controlled study. J Dermatol Treatm 1991; 2: 95-97
37. Wahid Z, Butt J, Nishtar R. Multicentre double-blind study of efficacy and safety of terbinafine 1% cream compared with bifonazole 1% cream in patients with tinea pedis moccasin type. J Dermatol Treat 1997; 8: 225-227
38. Sanchez Carazo JL, Fuente C, Oliver V, Umbert P. Estudio comparativo de terbinafina vs. bifonazol crema al 1% en aplicacion unica diaria en tina pedis. Actas-Dermo Sif 1994; 85: 388-394
39. Galimberti RL, Belli L, Negroni R, Castr JM, Rohwedder R, Tuculet MA. Prophylaxis of tinea pedis interdigitalis with bifonazole, 1% powder. Dermatologica 1984; 169: 111-116
40. Evans EGV, Seaman RAJ, James IGV. Short-duration therapy with terbinafine 1% cream in dermatophyte skin infections. Br J Dermatol 1994; 130: 83-87
41. Sugiura M, Hata Y, Fukuda T, Ishizaki S, Hanyaku H, Naka W, Harada T, Nishikawa T. One-week application of terbinafine cream compared with four-week application in treatment of tinea pedis. Nippon Ishinkin Gakkai Zasshi 2001; 42: 223-228